Besides, scRNA-seq analysis conducted on ESCC patients undergoing neoadjuvant chemoimmunotherapy, revealed that responders exhibit a higher proportion of CD8+ effector memory T cells but a lower proportion of CD4+ Tregs in TME [80]. The gene discussed is CD4; the disease is esophageal squamous cell carcinoma.